Regulation

Regulation

Attorneys General Call on Congress to Address Cannabis Edibles Packaged Like Popular Brands

The group wants Congress to step in and pass legislation that could curb so-called “copycat” THC products, which are particularly appealing to kids.

Regulation

Cannabis and Isomers like Delta-8 in Spotlight at Federal Testing Meeting

During the SAMHSA Drug Testing Advisory Board meeting, officials discussed emerging trends with cannabis-derived isomers.

Regulation

FDA Officials Wrestle with CBD in Day-Long Meeting on Science “Challenges”

The FDA still has more questions than answers on CBD, but it is making strides on conducting the research and collecting the data needed to release product regulations.

Regulation

FDA Meeting Will Spotlight “Challenges” With Cannabis Compounds in Foods and Supplements

The meeting, which will use cannabinoids as a “case study” in assessing the “safety” of certain foods and supplements, comes as the FDA wrestles with rulemaking for CBD products.

Regulation

FDA Warns Companies Against CBD in Animal Products

While cannabidiol products aren’t yet FDA approved for humans or animals, that hasn’t stopped plenty of sellers from marketing their products to treat, for example, animals’ anxiety.

Regulation

Cannabis Testing, Research, and the Future of Federal Regulation

A two-day event hosted by the Food and Drug Law Institute highlighted cannabis regulatory headaches, including delta-8 THC and a lack of uniformity in lab testing.

Regulation

FDA Commissioner Robert Califf Says He is “Committed” to Finding a “Path” for CBD

The U.S. Food and Drug Administration has been working for years on rules for products containing cannabis-derived compounds like CBD. But nothing has yet materialized.

Regulation, Research

FDA Researchers Publish First Study on Medical Cannabis Testing Patchwork

The research comes amid a broader agency effort to collect data on cannabinoids, which will help shape forthcoming rules on approved products.

CBD, Regulation

FDA Issues More CBD Warning Letters, With a Focus on Covid Claims

The 2018 Farm Bill legalized hemp, and, by extension, hemp-derived CBD, but the Food and Drug Administration has not yet released rules to guide the growing industry.

CBD, Regulation

FDA Reiterates Need for Cannabinoid Data in Webinar on Research and Regulation

The Food and Drug Administration has said for years that it is working on rules for cannabinoid-containing products. But it has also said that crucial research and data are lacking.

Regulation

Cannabis is Federally Illegal. But the Groundwork for Federal Regulation is Being Laid

The federal law on cannabis has remained unchanged for more than half a century. Yet as states race toward legalization, federal agencies have begun to play catch up.

CBD, Regulation

FDA: The Cannabis Regulatory Landscape is “Complex”

A policy coordinator with the FDA’s Cannabis Product Committee spoke about CBD during a Food and Drug Law Institute event focused on cannabis.

CBD, Regulation

FDA Launches Biggest Cannabis Data Collection Plan Yet

The Food and Drug Administration has been on a march to collect cannabinoid-related data. The “Cannabis-Derived Products Data Acceleration Plan” released this month is its most robust effort.

CBD, Regulation

FDA Rejects Two Applications for CBD-based Dietary Supplements

Epidiolex strikes again: the FDA-approved CBD-based pharmaceutical is complicating other uses of CBD.

CBD, Regulation

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.

CBD, Regulation

Consumer Brands Association Pushes Lawmakers on CBD Amid FDA Inaction

The group, which includes Coca-Cola and Kellogg’s as members, says its membership is “CBD curious” but that the lack of federal regulation is keeping major brands at bay.